{
  "id": "606ad2ab94d57fd879000053",
  "type": "summary",
  "question": "Which pharmacogenetic test is recommended prior to administering carbamazepine and why?",
  "ideal_answer": "HLA-B\u221715:02 is known as a biomarker for carbamazepine (CBZ) induced Steven-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) in some Asian populations. Hence United States Federal Drug Administration (USFDA) recommends HLA-B\u221715:02 screening for Asian and other populations with a high prevalence of HLA-B\u221715:02, prior to the administration of carbamazepine.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27060780"
  ],
  "snippets": [
    {
      "text": "HLA-B\u221715:02 is known as a biomarker for carbamazepine (CBZ) induced Steven-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) in some Asian populations. Hence United States Federal Drug Administration (USFDA) recommends HLA-B\u221715:02 screening for Asian and other populations with a high prevalence of HLA-B\u221715:02, prior to the administration of carbamazepine. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27060780",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}